Editorial: New Insights Into Understanding and Managing NAFLD

• Óscar Escribano,
• Daniel E. Francés,
• Yolanda F. Otero,
• Javier Egea,
• Águeda González-Rodríguez,
• Águeda González-Rodríguez

Affiliations

Óscar Escribano

Laboratory of Hepatic and Cardiovascular Diseases, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, Madrid, Spain

Daniel E. Francés

Instituto de Fisiología Experimental (IFISE-CONICET), Rosario, Argentina

Yolanda F. Otero

Valbiotis, Riom, France

Javier Egea

Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain

Águeda González-Rodríguez

Metabolic Syndrome and Vascular Risk Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain

Águeda González-Rodríguez

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain